Novacyt (FR:ALNOV) has released an update.
Novacyt has launched two new multiplex qPCR tests for detecting gastrointestinal diseases in cats and dogs, debuting at the London Vet Show. These tests streamline the detection of six crucial pathogens, offering faster results and efficiency for veterinary laboratories. This innovation aligns with Novacyt’s commitment to enhancing diagnostic solutions in the veterinary sector.
For further insights into FR:ALNOV stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Deutsche Bank Pounds the Table on Tesla Stock
- ‘Breath of Fresh Air,’ Says Daniel Ives About Rivian Stock
- ‘It’s Not Too Late to Load Up,’ Says Analyst About Nvidia Stock
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
